Vicus Capital Purchases Shares of 3,107 Marsh & McLennan Companies, Inc. $MRSH

Vicus Capital acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,107 shares of the financial services provider’s stock, valued at approximately $539,000.

Several other institutional investors have also recently added to or reduced their stakes in MRSH. Vanguard Group Inc. grew its holdings in Marsh & McLennan Companies by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 46,589,633 shares of the financial services provider’s stock valued at $8,643,309,000 after buying an additional 387,100 shares during the period. State Street Corp purchased a new position in shares of Marsh & McLennan Companies during the 4th quarter worth about $4,057,682,000. Capital International Investors acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter worth approximately $3,482,557,000. Capital World Investors grew its holdings in Marsh & McLennan Companies by 0.5% in the third quarter. Capital World Investors now owns 17,702,898 shares of the financial services provider’s stock valued at $3,567,410,000 after purchasing an additional 92,767 shares during the period. Finally, Wellington Management Group LLP acquired a new position in Marsh & McLennan Companies during the fourth quarter worth approximately $2,967,927,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

MRSH has been the topic of a number of research analyst reports. Wells Fargo & Company decreased their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a report on Thursday, April 9th. Piper Sandler reduced their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Morgan Stanley dropped their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday, April 6th. Bank of America reduced their price objective on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a research note on Tuesday, April 14th. Finally, Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price for the company in a report on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus price target of $200.19.

Marsh & McLennan Companies Price Performance

NYSE MRSH opened at $166.35 on Tuesday. The firm has a market cap of $80.37 billion, a PE ratio of 20.79, a PEG ratio of 2.46 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $219.71. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSH) last released its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.21 by $0.08. The firm had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, equities research analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.